Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

905 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP.
Gatti M, Rinaldi M, Tonetti T, Siniscalchi A, Viale P, Pea F. Gatti M, et al. Antibiotics (Basel). 2024 Mar 25;13(4):296. doi: 10.3390/antibiotics13040296. Antibiotics (Basel). 2024. PMID: 38666972 Free PMC article.
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections.
Gatti M, Cojutti PG, Pascale R, Tonetti T, Laici C, Dell'Olio A, Siniscalchi A, Giannella M, Viale P, Pea F. Gatti M, et al. Antibiotics (Basel). 2021 Oct 27;10(11):1311. doi: 10.3390/antibiotics10111311. Antibiotics (Basel). 2021. PMID: 34827249 Free PMC article.
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization.
Cojutti PG, Gatti M, Rinaldi M, Tonetti T, Laici C, Mega C, Siniscalchi A, Giannella M, Viale P, Pea F. Cojutti PG, et al. Among authors: gatti m. Front Pharmacol. 2021 Dec 8;12:781892. doi: 10.3389/fphar.2021.781892. eCollection 2021. Front Pharmacol. 2021. PMID: 34955851 Free PMC article.
An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients.
Gatti M, Viaggi B, Rossolini GM, Pea F, Viale P. Gatti M, et al. Antibiotics (Basel). 2021 Dec 28;11(1):33. doi: 10.3390/antibiotics11010033. Antibiotics (Basel). 2021. PMID: 35052910 Free PMC article.
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis.
Gatti M, Tedeschi S, Trapani F, Ramirez S, Mancini R, Giannella M, Viale P, Pea F. Gatti M, et al. Antibiotics (Basel). 2022 Aug 1;11(8):1037. doi: 10.3390/antibiotics11081037. Antibiotics (Basel). 2022. PMID: 36009906 Free PMC article.
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia.
Gatti M, Giannella M, Rinaldi M, Gaibani P, Viale P, Pea F. Gatti M, et al. Antibiotics (Basel). 2022 Dec 2;11(12):1739. doi: 10.3390/antibiotics11121739. Antibiotics (Basel). 2022. PMID: 36551398 Free PMC article.
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF).
Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Tonetti T, Giannella M, Viale P, Pea F. Gatti M, et al. J Crit Care. 2023 Aug;76:154301. doi: 10.1016/j.jcrc.2023.154301. Epub 2023 Apr 12. J Crit Care. 2023. PMID: 37059003 Free article.
905 results